These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 32412777)
1. LncRNA Chen D; Chen J; Gao J; Zhang Y; Ma Y; Wei W; Wei Y Cancer Biother Radiopharm; 2020 Jun; 35(5):319-328. PubMed ID: 32412777 [No Abstract] [Full Text] [Related]
2. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1. Zhang M; Xu Y; Yin S; Qiu F Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049 [TBL] [Abstract][Full Text] [Related]
3. DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p. Li Q; Wang S; Wu Z; Liu Y Biomed Pharmacother; 2020 Jul; 127():110164. PubMed ID: 32422563 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway. Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011 [TBL] [Abstract][Full Text] [Related]
5. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis. Ren Z; Liu X; Si Y; Yang D Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):572-583. PubMed ID: 32054332 [TBL] [Abstract][Full Text] [Related]
7. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway. Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346 [TBL] [Abstract][Full Text] [Related]
8. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA long intergenic non-protein coding RNA 1232 promotes cell proliferation, migration and invasion in bladder cancer via modulating miR-370-5p/PIM3 axis. Feng F; Yang J; Chen A; Cui M; Li L J Tissue Eng Regen Med; 2022 Jun; 16(6):575-585. PubMed ID: 35338769 [TBL] [Abstract][Full Text] [Related]
10. LncRNA ZEB2-AS1 promotes bladder cancer cell proliferation and inhibits apoptosis by regulating miR-27b. Wu X; Yan T; Wang Z; Wu X; Cao G; Zhang C Biomed Pharmacother; 2017 Dec; 96():299-304. PubMed ID: 28992472 [TBL] [Abstract][Full Text] [Related]
11. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis. Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264 [TBL] [Abstract][Full Text] [Related]
12. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway. Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524 [TBL] [Abstract][Full Text] [Related]
13. LncRNA DDX11-AS1 promotes cell growth, migration and invasion through regulating epithelial-mesenchymal transition in breast cancer. Xi X; Yang F; Ding Z; Zhuang H; Yuan H Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):40-44. PubMed ID: 38678629 [TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer. Song W; Qian Y; Zhang MH; Wang H; Wen X; Yang XZ; Dai WJ Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3049-3061. PubMed ID: 32271422 [TBL] [Abstract][Full Text] [Related]
15. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis. Ding Y; Huang Y; Zhang F; Gong L; Liang C; Ding K; He X; Ding X; Chen Y J Transl Med; 2023 Nov; 21(1):854. PubMed ID: 38008726 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1. Gao Z; Li S; Zhou X; Li H; He S Cancer Med; 2020 Oct; 9(20):7695-7705. PubMed ID: 32862492 [TBL] [Abstract][Full Text] [Related]
17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis. Tian JB; Cao L; Dong GL Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5714-5729. PubMed ID: 31298324 [TBL] [Abstract][Full Text] [Related]
19. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis. Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440 [TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA Yang X; Wei X; Yi C; Yang Y; Fang Z; Dai Y; Guo Y; Song D DNA Cell Biol; 2022 Feb; 41(2):179-189. PubMed ID: 35007433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]